• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[结核病治疗期间失访状态的预测因素]

[Predictive factors of lost to follow-up status during tuberculosis treatment].

作者信息

Horo K, Kouassi A B, Brou-Gode C V, Ahui J-M B, Diaw A, Kone-Konate F, Toure K, Gnaze A Z, N'Gom S A, Koffi B N, Aka-Danguy E

机构信息

Service de pneumologie du CHU de Cocody, BP 582 Abidjan cedex 03, Côte d'Ivoire.

出版信息

Rev Mal Respir. 2011 Sep;28(7):894-902. doi: 10.1016/j.rmr.2011.01.012. Epub 2011 Jun 23.

DOI:10.1016/j.rmr.2011.01.012
PMID:21943535
Abstract

INTRODUCTION

Patients with contagious tuberculosis who are lost to follow-up risk sowing the disease among their circle of acquaintances. Moreover, a history of inadequate anti-tuberculous treatment is an important risk factor for the development of drug-resistant organisms. The purpose of this study was to identify risk factors for loss to follow-up among patients undergoing treatment for tuberculosis.

METHODOLOGY

We performed a prospective cohort study among patients with contagious tuberculosis, beginning with anti-tuberculous treatment followed during six months, after initial education-information about their condition. We compared the characteristics of 152 patients lost to follow-up from tuberculosis treatment against those of 492 patients who were not lost to follow-up.

RESULTS

Independent factors associated with a reduction in the risk of being lost to follow-up were: the presence of night-sweats (OR=0.46 [0.24-0.88]; P=0.018), the presence of thoracic pain (OR=0.27 [0.14-0.54]; P<0.001), screening for HIV (OR=0.41 [0.17-0.98]; P=0.045), fact to inform a person of its disease (OR=0.06 [0.01-0.41]; P=0.004), the application of directly observed treatment in the community (OR=0.34 [0.17-0.66]; P<0.001).

CONCLUSION

Reducing loss to follow-up during treatment for tuberculosis requires the development of a "good attitude" through education-information about tuberculosis.

摘要

引言

失访的传染性结核病患者有将疾病传播给其熟人圈子的风险。此外,抗结核治疗不充分的病史是耐药菌产生的重要危险因素。本研究的目的是确定结核病治疗患者失访的危险因素。

方法

我们对传染性结核病患者进行了一项前瞻性队列研究,从抗结核治疗开始,在最初告知患者病情相关信息后随访6个月。我们比较了152例结核病治疗失访患者与492例未失访患者的特征。

结果

与降低失访风险相关的独立因素包括:盗汗(比值比[OR]=0.46[0.24-0.88];P=0.018)、胸痛(OR=0.27[0.14-0.54];P<0.001)、HIV筛查(OR=0.41[0.17-0.98];P=0.045)、告知他人自己病情这一事实(OR=0.06[0.01-0.41];P=0.004)、在社区实施直接观察治疗(OR=0.34[0.17-0.66];P<0.001)。

结论

减少结核病治疗期间的失访需要通过结核病相关的教育信息培养“良好态度”。

相似文献

1
[Predictive factors of lost to follow-up status during tuberculosis treatment].[结核病治疗期间失访状态的预测因素]
Rev Mal Respir. 2011 Sep;28(7):894-902. doi: 10.1016/j.rmr.2011.01.012. Epub 2011 Jun 23.
2
Abandonment of therapy in multidrug-resistant tuberculosis: Associated factors in a region with a high burden of the disease in Perú.耐多药结核病治疗的放弃:秘鲁一个疾病负担沉重地区的相关因素
Biomedica. 2019 Aug 1;39(Supl. 2):44-57. doi: 10.7705/biomedica.v39i3.4564.
3
[Antitubercular drug treatment failure and HIV infection in Abidjan (Ivory Coast)].[阿比让(科特迪瓦)的抗结核药物治疗失败与艾滋病毒感染]
Bull Soc Pathol Exot. 2003 Mar;96(1):39-40.
4
[Multi-drug resistance of tuberculosis: 81 patients monitored in an Ivory Coast pneumology unit].[结核病的多重耐药性:在科特迪瓦一家肺病科监测的81例患者]
Rev Pneumol Clin. 2011 Apr;67(2):82-8. doi: 10.1016/j.pneumo.2010.06.002. Epub 2010 Dec 3.
5
[Evaluation of multidrug-resistant tuberculosis treatment in Ivory Coast from 2008 to 2010].[2008年至2010年象牙海岸耐多药结核病治疗评估]
Rev Pneumol Clin. 2013 Dec;69(6):315-9. doi: 10.1016/j.pneumo.2013.08.002. Epub 2013 Oct 31.
6
Primary resistance to antituberculosis drugs: a national survey conducted in Côte d'Ivoire in 1995-1996. Ivoirian Study Group on Tuberculosis Resistance.对抗结核药物的原发性耐药:1995 - 1996年在科特迪瓦进行的一项全国性调查。科特迪瓦结核病耐药问题研究小组。
Int J Tuberc Lung Dis. 1999 Sep;3(9):805-9.
7
[Epidemiological, clinical and biological profile of resistant or recurrent pulmonary tuberculosis in Abidjan].[阿比让耐药或复发性肺结核的流行病学、临床和生物学特征]
Bull Soc Pathol Exot. 2004;97(5):336-7.
8
Tuberculosis treatment default among Brazilian children.巴西儿童的结核病治疗中断情况。
Int J Tuberc Lung Dis. 2006 Aug;10(8):864-9.
9
[Antitubercular chemotherapy].[抗结核化疗]
Rev Mal Respir. 1997 Dec;14 Suppl 5:S88-104.
10
[Clinical, microbiological and evolutionary profile of patients experiencing failures and relapses of tuberculosis in Ivory Coast].
Rev Pneumol Clin. 2015 Feb;71(1):20-6. doi: 10.1016/j.pneumo.2014.11.002. Epub 2015 Feb 11.